目的 观察烧伤患者血浆凝溶胶蛋白水平及变化规律,探讨凝溶胶蛋白水平与患者预后的关系。
方法 采用前瞻性队列研究的方式,选取2010年1月-2013年6月收治的98例烧伤面积≥30%总体表面积患者作为研究对象,分别按照烧伤面积大小、是否出现脓毒症以及脓毒症患者是否死亡分组,比较不同组别患者血浆凝溶胶蛋白水平及变化趋势。
结果 伤后7 d患者的血浆凝溶胶蛋白水平处于最低值,与其他时间点比较差异有统计学意义(P<0.001)。血浆凝溶胶蛋白浓度随着烧伤面积增大而降低(P<0.001)。脓毒症患者血浆凝溶胶蛋白总体均数水平低于非脓毒症患者,差异有统计学意义(F=1 035.41,P<0.001)。脓毒症死亡患者血浆凝溶胶蛋白总体均数水平低于存活患者,差异有统计学意义(F=958.69,P<0.001);伤后7~21 d的血浆凝溶胶蛋白水平低于伤后3 d及入院当天,差异有统计学意义(P<0.001)。
结论 烧伤可导致患者血浆凝溶胶蛋白水平降低,烧伤面积越大、合并脓毒症患者的血浆凝溶胶蛋白越低。血浆凝溶胶蛋白是反映大面积烧伤患者预后的一项重要监测指标。
Citation:
李先慧, 王晓娟, 刘德贵, 杨勇, 张彦标, 薛刚. 烧伤患者血浆凝溶胶蛋白水平及其与预后的关系研究. West China Medical Journal, 2016, 31(12): 2027-2029. doi: 10.7507/1002-0179.201600555
Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1. |
Huang F, Yao M, Li F, et al. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients[J]. PLoS One, 2011, 6(11):e25748.
|
2. |
Jin Y, Li Y, Qiu L, et al. Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury[J]. J Crit Care, 2012, 27(5):527.e1-527.e6.
|
3. |
Cohen S, Bucki Robert, Byfield J, et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis[J]. Cytokine, 2011, 54(3):235-238.
|
4. |
黄立峰, 龚平, 姚咏明, 等.凝溶胶蛋白与脓毒症[J].中华老年多器官疾病杂志, 2011, 10(5):469-472.
|
5. |
祝筱梅, 姚咏明, 盛志勇, 等.凝溶胶蛋白与创伤后的炎症反应[J].生理科学进展, 2010, 41(4):279-282.
|
6. |
Sadzyński A, Kurek K, Konończuk T, et al. Gelsolin-variety of structure and functions[J]. Postepy Hig Med Dosw (Online), 2010, 64(2):303-309.
|
7. |
Lee S, Bhan I, Thadhani R. The potential role of plasma gelsolin in dialysis-related protein-energy wasting[J]. Blood Purif, 2010, 29(2):99-101.
|
8. |
Zhang QH, Chen Q, Kang JR, et al. Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury[J]. J Neuroinflammation, 2011, 8(1):118.
|
9. |
Xu F, Liu G, Dong Q, et al. Change in plasma gelsolin level after traumatic brain injury[J]. J Trauma, 2011, 72(2):491-496.
|
- 1. Huang F, Yao M, Li F, et al. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients[J]. PLoS One, 2011, 6(11):e25748.
- 2. Jin Y, Li Y, Qiu L, et al. Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury[J]. J Crit Care, 2012, 27(5):527.e1-527.e6.
- 3. Cohen S, Bucki Robert, Byfield J, et al. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis[J]. Cytokine, 2011, 54(3):235-238.
- 4. 黄立峰, 龚平, 姚咏明, 等.凝溶胶蛋白与脓毒症[J].中华老年多器官疾病杂志, 2011, 10(5):469-472.
- 5. 祝筱梅, 姚咏明, 盛志勇, 等.凝溶胶蛋白与创伤后的炎症反应[J].生理科学进展, 2010, 41(4):279-282.
- 6. Sadzyński A, Kurek K, Konończuk T, et al. Gelsolin-variety of structure and functions[J]. Postepy Hig Med Dosw (Online), 2010, 64(2):303-309.
- 7. Lee S, Bhan I, Thadhani R. The potential role of plasma gelsolin in dialysis-related protein-energy wasting[J]. Blood Purif, 2010, 29(2):99-101.
- 8. Zhang QH, Chen Q, Kang JR, et al. Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury[J]. J Neuroinflammation, 2011, 8(1):118.
- 9. Xu F, Liu G, Dong Q, et al. Change in plasma gelsolin level after traumatic brain injury[J]. J Trauma, 2011, 72(2):491-496.